Design, Synthesis, and Biological Evaluation of the First Podophyllotoxin Analogues as Potential Vascular-Disrupting Agents

被引:34
作者
Labruere, Raphael [1 ,2 ]
Gautier, Benoit [2 ]
Testud, Marlene [1 ]
Seguin, Johanne [3 ]
Lenoir, Christine [2 ]
Desbene-Finck, Stephanie [1 ]
Helissey, Philippe [1 ]
Garbay, Christiane [2 ]
Chabot, Guy G. [3 ]
Vidal, Michel [2 ]
Giorgi-Renault, Sylviane [1 ]
机构
[1] Univ Paris 05, Chim Therapeut Lab, CNRS, Fac Sci Pharmaceut & Biol,UMR 8638, F-75270 Paris 06, France
[2] Univ Paris 05, Lab Pharmacochim Mol & Cellulaire, INSERM, U648,UFR Biomed, F-75006 Paris, France
[3] CNRS, Lab Pharmacol Chim Genet & Imagerie, INSERM, U1022,UMR 8151, F-75270 Paris 06, France
关键词
antitumor agents; antivascular agents; azapodophyllotoxins; nitrogen heterocycles; podophyllotoxin analogues; CANCER-THERAPY; TUMOR VASCULATURE; NATURAL-PRODUCTS; COLCHICINE SITE; TUBULIN; DERIVATIVES; BINDING; DRUGS; 4-AZA-2,3-DIDEHYDROPODOPHYLLOTOXIN; MICROTUBULES;
D O I
10.1002/cmdc.201000305
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We designed and synthesized two novel series of azapodophyllotoxin analogues as potential antivascular agents. A linker was inserted between the trimethoxyphenyl ring E and the tetracyclic ABCD moiety of the 4-aza-1,2-didehydropodophyllotoxins. In the first series, the linker enables free rotation between the two moieties; in the second series, conformational restriction of the E nucleus was considered. We have identified several new compounds with inhibitory activity toward tubulin polymerization similar to that of CA-4 and colchicine, while displaying low cytotoxic activity against normal and/or cancer cells. An aminologue and a methylenic analogue were shown to disrupt endothelial cell cords on Matrigel at subtoxic concentrations, and an original assay of drug washout allowed us to demonstrate the rapid reversibility of this effect. These two new analogues are promising leads for the development of vascular-disrupting agents in the podophyllotoxin series.
引用
收藏
页码:2016 / 2025
页数:10
相关论文
共 43 条
  • [1] Bane S.L., 2007, MICROTUBULE PROTOCOL, P281
  • [2] A fluorescence-based high-throughput assay for antimicrotubule drugs
    Barron, DM
    Chatterjee, SK
    Ravindra, R
    Roof, R
    Baloglu, E
    Kingston, DGI
    Bane, S
    [J]. ANALYTICAL BIOCHEMISTRY, 2003, 315 (01) : 49 - 56
  • [3] Bestmann H. J., 1979, ANGEW CHEM, V91, P748
  • [4] Podophyllotoxin derivatives: Drug discovery and development
    Bohlin, L
    Rosen, B
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (08) : 343 - 351
  • [5] BONNE D, 1985, J BIOL CHEM, V260, P2819
  • [6] Endothelium in vitro: A review of human vascular endothelial cell lines for blood vessel-related research
    Bouïs D.
    Hospers G.A.P.
    Meijer C.
    Molema G.
    Mulder N.H.
    [J]. Angiogenesis, 2001, 4 (2) : 91 - 102
  • [7] VASCULAR TARGETING - A NEW APPROACH TO THE THERAPY OF SOLID TUMORS
    BURROWS, FJ
    THORPE, PE
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (01) : 155 - 174
  • [8] CARMICHAEL J, 1987, CANCER RES, V47, P936
  • [9] Chaplin DJ, 1999, BRIT J CANCER, V80, P57
  • [10] Davis PD, 2002, CANCER RES, V62, P7247